Sign up
Quantellect · Congress · Issuer Profile
NASDAQ: AMGNAmgen Inc
HealthcareMkt Cap $251.89BCongress ownership rank #76

Amgen Inc Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 257 trades in Amgen Inc (NASDAQ: AMGN) since 2013, across 58 members, worth an estimated $4.1M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 142 buys against 115 sells, a modestly buy-led skew, with Democratic members responsible for 55% of the trades and Republican members 45%. The most recent disclosure shown was filed November 2026, and Rohit Khanna has filed the most AMGN transactions among those shown, with 15. Other recent filers include David J. Taylor, Sheldon Whitehouse, and Maria Elvira Salazar. One notable disclosed move was a purchase by David J. Taylor on January 16, 2026, up 36.3% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Amgen Inc's current Quantellect Tide Score is 73 out of 100 (High Tide); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Amgen Inc (AMGN) stock overview and the complete trade table below.

Data updated

Trades
31
Politicians
5
Filings
21
Disclosed Vol
$542.02K
Buys
13
42%
Sells
18
58%

Price & congressional trade timeline

Party breakdown

Amgen congressional trading activity

PoliticianPublishedTradedFiled AfterTypeSizeReturnOwner
Nov 12, 2026Nov 3, 20269 daysSell
$1,001 - $15,000
-3.77%Self
Nov 12, 2026Nov 3, 20269 daysSell
$1,001 - $15,000
-3.77%Self
Nov 2, 2026Oct 15, 202618 daysSell
$15,001 - $50,000
+2.27%Spouse
Nov 5, 2026Oct 7, 202629 daysSell
$1,001 - $15,000
+7.46%Spouse
Oct 1, 2026Sep 22, 20269 daysBuy
$1,001 - $15,000
+8.20%Self
Oct 7, 2026Sep 4, 202633 daysBuy
$1,001 - $15,000
+1.52%Spouse
Sep 5, 2026Aug 26, 202610 daysSell
$1,001 - $15,000
+0.81%Self
Sep 5, 2026Aug 26, 202610 daysSell
$1,001 - $15,000
+0.81%Self
Sep 2, 2026Aug 12, 202621 daysSell
$1,001 - $15,000
+6.66%Spouse
Aug 7, 2026Jul 20, 202618 daysSell
$1,001 - $15,000
+21.89%Spouse
Go to

Amgen (AMGN) congressional trading FAQ

Can members of Congress legally trade Amgen (AMGN) stock?

Yes. Members of Congress are permitted to trade individual stocks, including Amgen (AMGN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.

Are congressional Amgen (AMGN) trades public?

Yes. Every congressional trade in Amgen (AMGN) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.

How many times has Congress traded Amgen (AMGN)?

Members of Congress have disclosed 257 trades in Amgen (AMGN) worth $4.1M across 58 members, according to public STOCK Act filings.

Which members of Congress have traded Amgen (AMGN)?

Recent and active filers of Amgen (AMGN) disclosures include Rohit Khanna, David J. Taylor, Sheldon Whitehouse. The full member-by-member trade list is on this page.

Do Democrats or Republicans trade Amgen (AMGN) more?

Across disclosed Amgen (AMGN) trades, 55% were by Democrats and 45% by Republicans, led by Democrats (55%).

What is the most recent congressional Amgen (AMGN) trade?

The most recent disclosed Amgen (AMGN) filing reported a sell by David J. Taylor, filed Nov 11, 2026.

What is Amgen (AMGN)'s Tide Score?

Amgen (AMGN) has a Quantellect Tide Score of 73 (High Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.

Browse all stocks Congress tradesCongressional trading overviewAmgen (AMGN) stock overview

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.